Amy Katheryn Case, RN/CDE Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 427 Highway 51 N, Brookhaven, MS 39601 Phone: 601-835-9118 Fax: 601-835-9193 |
Justin Douglas, Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 427 Highway 51 N, Brookhaven, MS 39601 Phone: 601-835-9275 Fax: 888-965-6812 |
Ms. Kiara Diontea Merchant, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 624 S Second St, Brookhaven, MS 39601 Phone: 601-669-7357 |
Jaci King, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2135 Zetus Rd Nw, Brookhaven, MS 39601 Phone: 601-757-9927 |
Kline Foster, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2259 Old Red Star Dr Nw, Brookhaven, MS 39601 Phone: 601-754-7571 |
Lashonda Carmel, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2443 Fortune Rd Ne, Brookhaven, MS 39601 Phone: 601-867-1292 |
Bathsheba Brown, Registered Nurse - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 760 Brookman Dr Ext, Brookhaven, MS 39601 Phone: 601-823-5700 |
Marcus L Johnson, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 427 Highway 51 N, Brookhaven, MS 39601 Phone: 601-833-6011 |
Tonya Lacoria Mcmorris, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 725 Brookman Dr Ext, Brookhaven, MS 39601 Phone: 601-823-2300 |
Thomas Mcmahon, Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 427 Highway 51 N, Brookhaven, MS 39601 Phone: 601-835-9275 Fax: 888-965-6812 |
News Archive
"More than 400 Kenyan AIDS activists have demonstrated in the capital, Nairobi, demanding that the U.S. President's Emergency Plan for AIDS Relief release some $500 million for HIV programs in Kenya that is stuck in the pipeline," PlusNews reports.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology. The new automated workstation provides a faster and more economical automated solution to agarose gel selection of DNA fragments, generating high-quality material for downstream use in next-generation sequencing (NGS), cloning and gene synthesis applications.
Eli Lilly and Company and AstraZeneca today announced enrollment of the first patient into AMARANTH, a Phase II/III study of an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.
› Verified 7 days ago